国际皮肤性病学杂志    0  (): 352-354   ISSN: 2096-5540  CN: 32-1880/R   黄褐斑的治疗现状 吴艳华, 李其林 暨南大学医学院第四附属医院、广州市红十字会医院中医科 收稿日期 2005-03-18  修回日期 null  网络版发布日期 null 参考文献  [1] Huh CH, Seo KI, Park JY, et al. A randomized, double-blind, place bo-controlled trial of vitamin C iontophoresis in melasma. Dermatology, 2003, 206:316-320. [2] Tantcheva LP, Stoeva ES, Galabov AS, et al. Effect of vitamin E and vitamin C combination on experimental influenza virus infection. Methods Find Exp Clin Pharmacol, 2003, 25:259-264. [3] Ni Z, Mu Y, Gulati O. Treatment of melasma with Pycnogenol. Phytother Res, 2002, 16:567-571. [4] Kubo I, Kinst-Hori I, Chaudhuri SK, et al. Flavonols from Heterotheca inuloides:tyrosinase inhibitory activity and structural criteria. Bioorg Med Chem, 2000, 8:1749-1755. [5] Kim YM, Yun J, Lee CK, et al. Oxyresveratrol and hydroxystilbene compounds. Inhibitory effect on tyrosinase and mechanism of action. J Biol Chem, 2002, 277:16340-16344. [6] Burkitt M J, Duncan J. Effects of trans-resveratrol on copper-depen dent hydroxyl-radical formation and DNA damage:evidence for hydroxyl-radical scavenging and a novel, glutathione-sparing mecha nism of action. Arch Biochem Biophys, 2000, 381:253-263. [7] Yamakoshi J, Sano A, Tokutake S, et al. Oral intake of proanthocyanidin-rich extract from grape seeds improves chloasma. Phy tother Res, 2004, 18:895-899. [8] Bagchi D, Garg A, Krohn RL, et al. Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. Res Commun Mol Pathol Pharmacol, 1997, 95:179-189. [9] Perez-Bernal A, Munoz-Perez MA, Camacho F. Management of facial hyperpigmentation. Am J Clin Dermatol, 2000, 1:261-268. [10] Kligman DE, Sadiq I, Pagnoni A, et al. High-strength tretinoin:a method for rapid retinization of facial skin. J Am Acad Dermatol, 1998, 39:S93-S97. [11] Espinal-Perez LE, Moncada B, Castanedo-Cazares JP. A doubleblind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma. Int J Dermatol, 2004, 43:604-607. [12] Lim JT. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatol Surg, 1999, 25:282-284. [13] Lirm JT, Tham SN. Glycolic acid peels in the treatment of melasma among Asian women. Dermatol Surg, 1997, 23:177-179. [14] Menter A. Rationale for the use of topical corticosteroids in melas ma. J Drugs Dermatol, 2004, 3:169-174. [15] Kar HK. Efficacy of beta-carotene topical application in melasma:An open clinical trial. Indian J Dermatol Venereol Leprol, 2002, 68:320-322 [16] Lee MH, Kim HJ, Ha DJ, et al. Therapeutic effect of topical application of linoleic acid and lincomycin in combination with betamethasone valerate in melasma patients. J Korean Med Sci, 2002, [17] :518-523.17.Raulin C, Schonermark MP, Greve B, et al. Q-switched ruby laser treatment of tattoos and benign pigmented skin lesions:a critical review. Ann Plast Surg, 1998, 41:555-565. [18] Manaloto RM, Alster T. Erbium:YAG laser resurfacing for refractory melasma. Dermatol Surg, 1999, 25:121-123. [19] Sarkar R, Kaur C, Bhalla M, et al. The combination of glycolic acid peels with a topical regimen in the treatment of melasma in darkskinned patients:a comparative study. Dermatol Surg, 2002, 28:828-832. [20] Taylor SC, Torok H, Jones T, et al. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. Cutis, 2003, 72:67-72. [21] Rendon MI. Utilizing combination therapy to optimize melasma out comes. J Drugs Dermatol, 2004, 3(5 Suppl):S27-S34. 通讯作者: